Senseonics Holdings Inc (SENS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$9.63-2.73%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · SENS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -8.9% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 72.6% |
Growth built into the price is above our model estimate.
The price assumes 81.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is on a run of consecutive earnings misses and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
SENS — earnings miss
Dated 2026-08-06
Results of Operations and Financial Condition. On August 6, 2026, Senseonics Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026, as well as information regarding a conference call to discuss these financial results and the Company’s recent corporate highlights and outlook. This press release has been furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by this reference. The information…
Why it matters: A successful launch in Europe is key for making more money and growth.
Watch forGood news about Eversense 365 use in Europe.
Also watch forBad feedback or delays for Eversense 365 launch in Europe.
Why it matters: A gross margin above 58% shows good cost management. It helps keep profits strong.
Supportive ifGross margin stays above 58% in Q3. This shows management can control costs well.
Worry ifGross margin falls below 58% in Q3. This suggests problems with cost management.
Why it matters: Improving operating income is vital for financial health. A decline would raise concerns.
Supportive ifOperating income improves to less negative than -$31.8M in Q2 2026.
Worry ifOperating income worsens to more negative than -$31.8M in Q2 2026.
Why it matters: Confirming revenue guidance of $60M - $64M shows strong growth momentum. It indicates the company is on track with its commercial strategy.
Supportive ifQ2 revenue guidance confirmed within the range of $60M - $64M.
Worry ifQ2 revenue guidance lowered below $60M.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$270 on $10,000 · ±2.7% | How much price usually moves either way. |
| Bad day | $707 loss on $10,000 · 7.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,699 loss on $10,000 · 57.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Meeting this target shows strong demand for Eversense 365 and supports growth plans.
Supportive ifQ2 revenue growth reaches or exceeds 70% year-over-year.
Worry ifQ2 revenue growth falls below 70% year-over-year.
Why it matters: The acquisition could help Senseonics grow and improve its market position. Investors will look for details on how this impacts revenue and operations.
Supportive ifA press release will explain how the acquisition will affect revenue.
Worry ifThere are no new updates. No negative comments about the acquisition's benefits.
Why it matters: High adoption rates show good marketing and product acceptance. This could help revenue grow.
Supportive ifNew patient adds for Eversense 365 increase by 100% each year.
Worry ifNew patient adds for Eversense 365 grow less than 50% year-over-year.
Why it matters: Better operating income is important for Senseonics. Good numbers may show better cost control.
Supportive ifOperating income is rising, increasing by at least 10% each quarter.
Worry ifOperating income keeps going down or stays the same.
Why it matters: Strong revenue growth shows that the company is doing well and supports its growth plans.
Supportive ifQ3 revenue growth is over 76% from last year. This shows strong demand for Eversense products.
Worry ifQ3 revenue growth is below 76% from last year. This may show problems in sales.
Why it matters: Good integration helps bring in more money. It also makes operations better.
Watch forManagement says integration is going well with no big problems.
Also watch forManagement points out big problems. They also mention delays in integration.
Why it matters: How well this offering does will affect funding for Eversense 365 and product work.
Watch forThe public offering ends well with strong interest.
Also watch forThe public offering fails to meet expectations or is postponed.
Why it matters: How well European revenue normalizes will show if the Ascensia change works.
Supportive ifIn Q3, revenue from Europe is about 20% of total revenue.
Worry ifQ3 revenue from Europe drops below 15% of total revenue.
Why it matters: Completing the $80 million offering could give needed funds for growth.
Supportive ifThe public offering ends successfully. The company receives the funds.
Worry ifThe public offering fails to close or is greatly reduced.
Why it matters: Revenue growth is on track, and updates could signal continued success or potential challenges. Investors want to see if growth can be sustained.
Supportive ifRevenue growth reported above 15% year over year in the next earnings report.
Worry ifRevenue growth reported below 5% year over year.
Why it matters: If revenue growth is below this level, it may show weaker sales for Eversense.
Worry ifQ3 revenue growth below 76% year-over-year.
Less concerning ifQ3 revenue growth of 76% or higher year-over-year.
Why it matters: A drop below this level may show problems with managing costs and pricing.
Worry ifGross margin reported below 58%.
Less concerning ifGross margin reported at 58% or higher.
Why it matters: Hitting this target would show effective scaling of Eon Care, a key growth driver.
Supportive ifEon Care nurse count reaches 100.
Worry ifEon Care nurse count remains below 100.